Previous studies have determined that the HDAC1/MTA1 complexes deacetylate the p53 protein and attenuate the transactivation function of p53 in human carcinoma, thereby inhibiting p53-induced apoptosis (18,24). The gene discussed is TP53; the disease is carcinoma.